Virax Biolabs Group (VRAX) Financial Statements & Analysis

Virax Biolabs Group Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Virax Biolabs Group Limited income statement - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020
Period ending	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Sep 2022	Mar 2022	Mar 2021	Mar 2020
Revenue & Gross Profit
Revenue	0.01	0.01	0.16	0.01	0.00	-	0.12	0.10
Cost of Revenue	0.00	0.06	0.11	0.01	0.00	-	0.13	0.05
Gross Profit	0.01	-0.05	0.05	0.00	0.00	-	-0.01	0.05
Operating Expenses
Research & Development	3.74	1.78	1.61	2.18	0.43	0.43	0.12	0.09
Selling, General & Administrative	2.67	4.33	4.57	3.55	1.30	1.30	0.51	0.61
Operating Expenses	6.41	6.11	6.19	5.73	1.73	1.73	0.64	0.70
Operating Income	-6.40	-6.16	-6.14	-5.73	-1.73	-1.73	-0.64	-0.65
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Interest Expense	0.06	0.06	0.03	-0.02	0.02	0.02	0.03	0.09
Other Income/Expense	0.59	-0.04	-0.58	-0.27	-0.02	0.00	-0.03	-0.09
Income
Income Before Tax	-5.93	-6.20	-6.74	-5.46	-1.75	-1.75	-0.67	-0.74
Income Tax Expense	-0.90	-0.14	0.00	0.00	0.00	-	0.00	0.00
Net Income	-5.02	-6.06	-6.73	-5.46	-1.71	-1.71	-0.65	-0.80
Net Income - Continuous Operations	-5.03	-6.06	-6.74	-5.46	-1.71	-1.75	-0.65	-0.80
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-
EBITDA	-6.05	-5.80	-6.61	-5.73	0.00	-1.73	-0.64	0.00
EBIT	-6.40	-6.15	-6.71	-5.73	-	-1.73	-0.64	-
Depreciation & Amortization	0.44	0.34	0.10	0.00	1.73	-	0.64	0.65
Earnings Per Share
Basic EPS	-13.00	-49.00	-84.00	-128.00	-37.00	-2.00	-14.00	-17.00
Diluted EPS	-13.00	-49.00	-84.00	-128.00	-37.00	-2.00	-14.00	-17.00
Basic Shares Outstanding	0.40	0.12	0.08	0.04	0.05	1.14	0.05	0.05
Diluted Shares Outstanding	0.40	0.12	0.08	0.04	0.05	1.14	0.05	0.05

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About Virax Biolabs Group Financial Statements

What was Virax Biolabs Group's revenue in fiscal 2026?

Virax Biolabs Group reported revenue of $12.42K in fiscal 2026 (fiscal year ended Mar 31, 2026). That was up 96.2% from $6.33K a year earlier.

Is Virax Biolabs Group profitable?

No. Virax Biolabs Group reported a net loss of $5.02M in fiscal 2026. In fiscal 2025 it lost $6.06M.

What is Virax Biolabs Group's operating margin?

Virax Biolabs Group's operating income was −$6.40M on revenue of $12.42K in fiscal 2026, an operating margin of -51515.2%, compared with -97344.8% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition